NCB-0970
NCB-0970 is the negative control of NCB-0846. NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation[1][2].
Product Specifications
CAS Number
2749881-54-5
UNSPSC
12352005
Target
MAP4K; TGF-beta/Smad; Wnt
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ncb-0970.html
Purity
98.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@H](CC1)CC[C@@H]1OC2=CC=CC3=C2N=C(NC4=CC=C(N=CN5)C5=C4)N=C3
Molecular Formula
C21H21N5O2
Molecular Weight
375.42
References & Citations
[1]Masuda M, et al. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun. 2016 Aug 26;7:12586. |[2]Sugano T, et al., Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846. Br J Cancer. 2021 Jan;124 (1) :228-236.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAP4K7/TNIK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS954038-01 0.02 mg (E-Coli)
Recombinant Human Collagen alpha-1(XVIII) chain
Sign In for Pricing
View Details MBS954038-02 0.1 mg (E-Coli)
Recombinant Human Collagen alpha-1(XVIII) chain
Sign In for Pricing
View Details MBS954038-03 1 mg (E-Coli)
Recombinant Human Collagen alpha-1(XVIII) chain
Sign In for Pricing
View Details MBS954038-04 5x 1 mg (E-Coli)
Recombinant Human Collagen alpha-1(XVIII) chain
Sign In for Pricing
View Details